1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 41 Hits
  • 検索条件 : 絞込み (MeSH = Deoxycytidine / analogs & derivatives*)
生物種 リソース名 タイトル
ヒト・動物細胞 HuCCT1(RCB1960) Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.
ヒト・動物細胞 TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.
ヒト・動物細胞 MCF7(RCB1904) Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine.
ヒト・動物細胞 HuCCT1(RCB1960) , SSP-25(RCB1293) , RBE(RCB1292) , YSCCC(RCB1549) , TGBC24TKB(RCB1196) , TFK-1(RCB2537) Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
遺伝子材料 PINK1_WT-IRES-GFP-NLS (RDB18946) , PINK1_KD-IRES-GFP-NLS (RDB18947) , MUL1_WT-IRES-GFP-NLS (RDB18948) , MUL1_LD-IRES-GFP-NLS (RDB18949) Gemcitabine induces Parkin-independent mitophagy through mitochondrial-resident E3 ligase MUL1-mediated stabilization of PINK1.
ヒト・動物細胞 HS-Sch-2(RCB2230) , YST-1(RCB2136) , HS-PSS(RCB2362) Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
ヒト・動物細胞 MIA Paca2(RCB2094) Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors.
ヒト・動物細胞 MBT-2(RCB0544) Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC.
ヒト・動物細胞 RERF-LC-AI(RCB0444) , RERF-LC-KJ(RCB1313) , LC-2/ad(RCB0440) , A549 Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.
ヒト・動物細胞 KP4(RCB1005) Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer.
ヒト・動物細胞 HuCCT1(RCB1960) , HuH-28(RCB1943) Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
ヒト・動物細胞 RBE(RCB1292) , HuCCT1(RCB1960) , SSP-25(RCB1293) , TGBC24TKB(RCB1196) , TFK-1(RCB2537) ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner.
ヒト・動物細胞 A549(RCB0098) Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.
ヒト・動物細胞 KP4(RCB1005) , PK-59(RCB1901) Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1.
ヒト・動物細胞 JHOC-9(RCB2226) Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.
ヒト・動物細胞 HuCCT1(RCB1960) , TKKK(RCB1907) , TGBC24TKB(RCB1196) Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines.
ヒト・動物細胞 M-MOK(RCB2534) A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.
ヒト・動物細胞 HuCCT1(RCB1960) Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.
ヒト・動物細胞 TFK-1(RCB2537) Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
ヒト・動物細胞 NOR-P1(RCB2139) Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells.